1-9 of 9
Neus Villamor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study

Alfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, Sebastián Casanueva-Eliceiry, Pablo Mozas, Laura Magnano, Natalia Castrejón de Anta, Jordina Rovira, Ivan Dlouhy, Silvia Martín, Miguel Osuna, Sonia Rodríguez, Marc Simó, Magda Pinyol, Tycho Baumann, Silvia Beà, Olga Balagué, Julio Delgado, Neus Villamor, Xavier Setoain, Elías Campo, Eva Giné, Armando López-Guillermo
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 513–521.
https://doi.org/10.1158/1078-0432.CCR-20-2558
Published: 19 January 2021
View article titled, Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
Open the PDF for Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study in another window
Includes: Supplementary data
Journal Articles

The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia

Alba Matas-Céspedes, Anna Vidal-Crespo, Vanina Rodriguez, Neus Villamor, Julio Delgado, Eva Giné, Heleia Roca-Ho, Pablo Menéndez, Elías Campo, Armando López-Guillermo, Dolors Colomer, Gaël Roué, Adrian Wiestner, Paul W.H.I. Parren, Parul Doshi, Jeroen Lammerts van Bueren, Patricia Pérez-Galán
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (6): 1493–1505.
https://doi.org/10.1158/1078-0432.CCR-15-2095
Published: 14 March 2017
View article titled, The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia
Open the PDF for The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome

Jordina Rovira, Kennosuke Karube, Alexandra Valera, Dolors Colomer, Anna Enjuanes, Lluís Colomo, Alejandra Martínez-Trillos, Eva Giné, Ivan Dlouhy, Laura Magnano, Julio Delgado, Antonio Martínez, Neus Villamor, Elías Campo, Armando López-Guillermo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2755–2764.
https://doi.org/10.1158/1078-0432.CCR-15-1525
Published: 31 May 2016
View article titled, <em>MYD88</em> L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome
Open the PDF for <em>MYD88</em> L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome in another window
Includes: Supplementary data
Journal Articles

Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib)

Alba Matas-Céspedes, Vanina Rodriguez, Susana G. Kalko, Anna Vidal-Crespo, Laia Rosich, Teresa Casserras, Patricia Balsas, Neus Villamor, Eva Giné, Elías Campo, Gaël Roué, Armando López-Guillermo, Dolors Colomer, Patricia Pérez-Galán
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3458–3471.
https://doi.org/10.1158/1078-0432.CCR-14-0154
Published: 30 June 2014
View article titled, Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib)
Open the PDF for Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib) in another window
Includes: Supplementary data
Journal Articles

p65 Activity and ZAP-70 Status Predict the Sensitivity of Chronic Lymphocytic Leukemia Cells to the Selective IκB Kinase Inhibitor BMS-345541

Mónica López-Guerra, Gaël Roué, Patricia Pérez-Galán, Roberto Alonso, Neus Villamor, Emili Montserrat, Elias Campo, Dolors Colomer
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2767–2776.
https://doi.org/10.1158/1078-0432.CCR-08-2382
Published: 15 April 2009
View article titled, p65 Activity and ZAP-70 Status Predict the Sensitivity of Chronic Lymphocytic Leukemia Cells to the Selective IκB Kinase Inhibitor BMS-345541
Open the PDF for p65 Activity and ZAP-70 Status Predict the Sensitivity of Chronic Lymphocytic Leukemia Cells to the Selective IκB Kinase Inhibitor BMS-345541 in another window
Journal Articles

Bendamustine Is Effective in p53-Deficient B-Cell Neoplasms and Requires Oxidative Stress and Caspase-Independent Signaling

Gaël Roué, Mónica López-Guerra, Pierre Milpied, Patricia Pérez-Galán, Neus Villamor, Emili Montserrat, Elias Campo, Dolors Colomer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 6907–6915.
https://doi.org/10.1158/1078-0432.CCR-08-0388
Published: 03 November 2008
View article titled, Bendamustine Is Effective in p53-Deficient B-Cell Neoplasms and Requires Oxidative Stress and Caspase-Independent Signaling
Open the PDF for Bendamustine Is Effective in p53-Deficient B-Cell Neoplasms and Requires Oxidative Stress and Caspase-Independent Signaling in another window
Journal Articles

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication

Francesc Bosch, Ana Ferrer, Neus Villamor, Marcos González, Javier Briones, Eva González-Barca, Eugenia Abella, Santiago Gardella, Lourdes Escoda, Elena Pérez-Ceballos, Antoni Asensi, Ma José Sayas, Llorenç Font, Albert Altés, Ana Muntañola, Paola Bertazzoni, María Rozman, Marta Aymerich, Eva Giné, Emili Montserrat
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 155–161.
https://doi.org/10.1158/1078-0432.CCR-07-1371
Published: 02 January 2008
View article titled, Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication
Open the PDF for Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication in another window
Journal Articles

Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy

Silvia Marcé, Olga Balagué, Luis Colomo, Antonio Martinez, Sylvia Höller, Neus Villamor, Francesc Bosch, German Ott, Andreas Rosenwald, Lorenzo Leoni, Manel Esteller, Mario F. Fraga, Emili Montserrat, Dolors Colomer, Elias Campo
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (12): 3754–3761.
https://doi.org/10.1158/1078-0432.CCR-05-2780
Published: 15 June 2006
View article titled, Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy
Open the PDF for Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy in another window
Journal Articles

ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia

Marta Crespo, Neus Villamor, Eva Giné, Ana Muntañola, Dolors Colomer, Teresa Marafioti, Margaret Jones, Mireia Camós, Elias Campo, Emili Montserrat, Francesc Bosch
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 726–734.
https://doi.org/10.1158/1078-0432.CCR-05-1531
Published: 07 February 2006
View article titled, ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia
Open the PDF for ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia in another window